报价延迟最少15分钟:2026/02/12 06:58 EST
盘前时段
|
||||
|
100.42 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
100.4
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-10.66/-9.49
|
|
企业价值
4.10B
|
| 资产负债 |
|
每股账面净值
57.46
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
93.11M
|
|
每股收益
--
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service. |
